Structure-activity relationship to investigate ligand selectivity for the acetylcholine binding site of the rat α4β2 and α3β4 nicotinic subtypes.

被引：0
|
作者：
Bisson, WH [1 ]
Westera, G [1 ]
Schubiger, PA [1 ]
Scapozza, L [1 ]
机构：
[1] Swiss Fed Inst Technol, Ctr Radiopharmaceut Sci, Dept Chem & Appl Biosci, CH-8091 Zurich, Switzerland
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2003年 / 226卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
243-MEDI
引用
收藏
页码：U45 / U45
页数：1
相关论文
共 50 条
  • [1] Ligand selectivity for the acetylcholine binding site of the rat α4β2 and α3β4 nicotinic subtypes investigated by molecular docking
    Bisson, WH
    Scapozza, L
    Westera, G
    Mu, LJ
    Schubiger, PA
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (16) : 5123 - 5130
  • [2] Structure-activity relationship and site of binding of polyamine derivatives at the nicotinic acetylcholine receptor
    Bixel, MG
    Krauss, M
    Liu, Y
    Bolognesi, ML
    Rosini, M
    Mellor, IS
    Usherwood, PNR
    Melchiorre, C
    Nakanishi, K
    Hucho, F
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (01): : 110 - 120
  • [3] Computational evidence for the ligand selectivity to the α4β2 and α3β4 nicotinic acetylcholine receptors
    Yuan, Hongbin
    Petukhov, Pavel A.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (23) : 7936 - 7942
  • [4] Characterization of Binding Site Interactions and Selectivity Principles in the α3β4 Nicotinic Acetylcholine Receptor
    Knox, Hailey J.
    Campello, Hugo Rego
    Lester, Henry A.
    Gallagher, Timothy
    Dougherty, Dennis A.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2022, 144 (35) : 16101 - 16117
  • [5] Structure-Activity Relationship of Truncated 4′-Selenonucleosides: A3 Adenosine Receptor Activity and Binding Selectivity
    Kim, Minjae
    Choi, Hongseok
    Nayak, Akshata
    Tripathi, Sushil K.
    Aswar, Vikas R.
    Gaikwad, Vidyasagar B.
    Jacobson, Kenneth A.
    Jeong, Lak Shin
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (09): : 1620 - 1626
  • [6] A Pharmacophore for Drugs Targeting the α4α4 Binding Site of the (α4)3(β2)2 Nicotinic Acetylcholine Receptor
    Kusay, Ali S.
    Luo, Yujia
    O'Mara, Megan L.
    Balle, Thomas
    JOURNAL OF NEUROCHEMISTRY, 2025, 169 (02)
  • [7] Agonists at the α4β2 nicotinic acetylcholine receptors:: Structure-activity relationships and molecular modelling
    Tonder, JE
    Olesen, PH
    CURRENT MEDICINAL CHEMISTRY, 2001, 8 (06) : 651 - 674
  • [8] Desnitroimidacloprid and nicotine binding site in rat recombinant α4β2 neuronal nicotinic acetylcholine receptor
    D'Amour, KA
    Casida, JE
    PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY, 1999, 64 (01) : 55 - 61
  • [9] Synthesis and structure-activity relationship of pyridinecarboxamide-based α4β2 selective neuronal nicotinic acetylcholine receptor ligands
    Shi, Lei
    Scanio, Marc J. C.
    Bunnelle, William H.
    Anderson, David J.
    Helfrich, Rosalind J.
    Malysz, John
    Lee, Chih-Hung
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [10] Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes
    Arias, Hugo R.
    Feuerbach, Dominik
    Targowska-Duda, Katarzyna
    Kaczor, Agnieszka A.
    Poso, Antti
    Jozwiak, Krzysztof
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2015, 1848 (02): : 731 - 741
12345